» Articles » PMID: 25642438

The Promise and Perils of HDAC Inhibitors in Neurodegeneration

Overview
Specialty Neurology
Date 2015 Feb 3
PMID 25642438
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylases (HDACs) represent emerging therapeutic targets in the context of neurodegeneration. Indeed, pharmacologic inhibition of HDACs activity in the nervous system has shown beneficial effects in several preclinical models of neurological disorders. However, the translation of such therapeutic approach to clinics has been only marginally successful, mainly due to our still limited knowledge about HDACs physiological role particularly in neurons. Here, we review the potential benefits along with the risks of targeting HDACs in light of what we currently know about HDAC activity in the brain.

Citing Articles

Elucidating epigenetic mechanisms governing odontogenic differentiation in dental pulp stem cells: an in-depth exploration.

Huang L, Chen X, Yang X, Zhang Y, Liang Y, Qiu X Front Cell Dev Biol. 2024; 12:1394582.

PMID: 38863943 PMC: 11165363. DOI: 10.3389/fcell.2024.1394582.


5-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner.

Meng Q, Guo J, Lv K, Liu Y, Zhang J, Li M Acta Pharm Sin B. 2024; 14(5):2153-2176.

PMID: 38799623 PMC: 11120280. DOI: 10.1016/j.apsb.2024.02.020.


Class I histone deacetylases inhibition reverses memory impairment induced by acute stress in mice.

Martinez-Pacheco H, Zepeda R, Picazo O, Quirarte G, Roldan-Roldan G PLoS One. 2024; 19(4):e0302374.

PMID: 38635564 PMC: 11025869. DOI: 10.1371/journal.pone.0302374.


The Protein Acetylation after Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities.

Li H, Zhang H Int J Med Sci. 2024; 21(4):725-731.

PMID: 38464830 PMC: 10920853. DOI: 10.7150/ijms.92222.


Long-range action of an HDAC inhibitor treats chronic pain in a spared nerve injury rat model.

Centeno M, Alam M, Haldar K, Apkarian A bioRxiv. 2024; .

PMID: 38168166 PMC: 10760082. DOI: 10.1101/2023.12.13.571583.


References
1.
Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y . Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem. 2007; 101(6):1491-1504. DOI: 10.1111/j.1471-4159.2006.04440.x. View

2.
Hogarth P, Lovrecic L, Krainc D . Sodium phenylbutyrate in Huntington's disease: a dose-finding study. Mov Disord. 2007; 22(13):1962-4. DOI: 10.1002/mds.21632. View

3.
Roth M, Chen W . Sorting out functions of sirtuins in cancer. Oncogene. 2013; 33(13):1609-20. PMC: 4295628. DOI: 10.1038/onc.2013.120. View

4.
DAVIDSON J, Riley B, Burright E, Duvick L, Zoghbi H, Orr H . Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein. Hum Mol Genet. 2000; 9(15):2305-12. DOI: 10.1093/oxfordjournals.hmg.a018922. View

5.
Rothgiesser K, Erener S, Waibel S, Luscher B, Hottiger M . SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci. 2010; 123(Pt 24):4251-8. DOI: 10.1242/jcs.073783. View